全文获取类型
收费全文 | 5133篇 |
免费 | 289篇 |
国内免费 | 33篇 |
专业分类
耳鼻咽喉 | 58篇 |
儿科学 | 140篇 |
妇产科学 | 101篇 |
基础医学 | 834篇 |
口腔科学 | 336篇 |
临床医学 | 419篇 |
内科学 | 1119篇 |
皮肤病学 | 142篇 |
神经病学 | 431篇 |
特种医学 | 73篇 |
外科学 | 473篇 |
综合类 | 18篇 |
一般理论 | 2篇 |
预防医学 | 470篇 |
眼科学 | 54篇 |
药学 | 394篇 |
中国医学 | 40篇 |
肿瘤学 | 351篇 |
出版年
2024年 | 7篇 |
2023年 | 90篇 |
2022年 | 188篇 |
2021年 | 334篇 |
2020年 | 199篇 |
2019年 | 251篇 |
2018年 | 245篇 |
2017年 | 181篇 |
2016年 | 201篇 |
2015年 | 224篇 |
2014年 | 320篇 |
2013年 | 349篇 |
2012年 | 473篇 |
2011年 | 473篇 |
2010年 | 232篇 |
2009年 | 174篇 |
2008年 | 276篇 |
2007年 | 260篇 |
2006年 | 269篇 |
2005年 | 188篇 |
2004年 | 161篇 |
2003年 | 117篇 |
2002年 | 100篇 |
2001年 | 18篇 |
2000年 | 17篇 |
1999年 | 11篇 |
1998年 | 18篇 |
1997年 | 14篇 |
1996年 | 10篇 |
1995年 | 9篇 |
1994年 | 6篇 |
1993年 | 6篇 |
1992年 | 7篇 |
1991年 | 1篇 |
1989年 | 2篇 |
1988年 | 2篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 2篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1978年 | 2篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有5455条查询结果,搜索用时 15 毫秒
991.
992.
Purpose
Studies conducted to assess the association between fish consumption and prostate cancer (PCA) risk are inconclusive. However, few studies have distinguished between fatty and lean fish, and no studies have considered the role of different cooking practices, which may lead to differential accumulation of chemical carcinogens. In this study, we investigated the association between fish intake and localized and advanced PCA taking into account fish types (lean vs. fatty) and cooking practices. 相似文献993.
994.
Slattery ML John EM Torres-Mejia G Lundgreen A Herrick JS Baumgartner KB Hines LM Stern MC Wolff RK 《Carcinogenesis》2012,33(8):1512-1521
Breast cancer incidence rates are characterized by unique racial and ethnic differences. Native American ancestry has been associated with reduced breast cancer risk. We explore the biological basis of disparities in breast cancer risk in Hispanic and non-Hispanic white women by evaluating genetic variation in genes involved in inflammation, insulin and energy homeostasis in conjunction with genetic ancestry. Hispanic (2111 cases, 2597 controls) and non-Hispanic white (1481 cases, 1586 controls) women enrolled in the 4-Corner's Breast Cancer Study, the Mexico Breast Cancer Study and the San Francisco Bay Area Breast Cancer Study were included. Genetic admixture was determined from 104 ancestral informative markers that discriminate between European and Native American ancestry. Twenty-one genes in the CHIEF candidate pathway were evaluated. Higher Native American ancestry was associated with reduced risk of breast cancer (odds ratio = 0.79, 95% confidence interval 0.65, 0.95) but was limited to postmenopausal women (odds ratio = 0.66, 95% confidence interval 0.52, 0.85). After adjusting for genetic ancestry and multiple comparisons, four genes were significantly associated with breast cancer risk, NFκB1, NFκB1A, PTEN and STK11. Within admixture strata, breast cancer risk among women with low Native American ancestry was associated with IkBKB, NFκB1, PTEN and RPS6KA2, whereas among women with high Native American ancestry, breast cancer risk was associated with IkBKB, mTOR, PDK2, PRKAA1, RPS6KA2 and TSC1. Higher Native American ancestry was associated with reduced breast cancer risk. Breast cancer risk differed by genetic ancestry along with genetic variation in genes involved in inflammation, insulin, and energy homeostasis. 相似文献
995.
996.
997.
Objectives.
The objective of this study was to evaluate the effect of tamoxifen on blood markers that are associated with cardiovascular risk, such as C-reactive protein (CRP), apolipoprotein A-1 (Apo-A), and apolipoprotein B-100 (Apo-B), in women undergoing chemotherapy for breast cancer.Methods.
Over a period of 12 months, we followed 60 women with breast cancer. The women were divided into the following groups: a group that received only chemotherapy (n = 23), a group that received chemotherapy plus tamoxifen (n = 21), and a group that received only tamoxifen (n = 16). Plasma CRP levels were assessed at 0, 3, 6, and 12 months, and Apo-A and Apo B levels as well as the Apo-B/Apo-A ratio were assessed at 0 and 12 months.Results.
We found increases in the plasma concentration of CRP in the chemotherapy alone and chemotherapy plus tamoxifen groups after 3 and 6 months of treatment (before the introduction of tamoxifen). However, after 12 months of treatment, women who used tamoxifen (the chemotherapy plus tamoxifen and tamoxifen alone groups) showed a significant reduction in CRP and Apo-B levels and a decrease in the Apo-B/Apo-A ratio. A significant increase in serum Apo-A levels was observed in the group receiving chemotherapy alone as a treatment for breast cancer.Conclusion.
The use of tamoxifen after chemotherapy for the treatment of breast cancer significantly reduces the levels of cardiovascular disease risk markers (CRP, Apo-B, and the Apo-B/Apo-A ratio). 相似文献998.
999.
1000.